BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Deals

  ConsumerMedical Closes Strategic Equity Investment in InfiniteMD

  Deal marks further expansion into virtual consultations with network of nation’s top physicians for patients with rare and serious diagnoses and those living outside of the U.S.

  January 9, 2020

   · 

  4 min read
• Business

  REGENXBIO Reports Continued Progress Across Programs in Year-End 2019 Corporate Update

  REGENXBIO Inc., a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV® Technology Platform, provided a year-end 2019 corporate update and anticipated milestones for 2020.

  January 9, 2020

   · 

  16 min read
• Business

  Aro Biotherapeutics and Ionis Enter Licensing and Collaboration Agreement Focused on Cell-Specific Delivery of Antisense Oligonucleotides

  Ionis to leverage Aro’s CENTYRIN technology to develop a new class of innovative medicines designed to selectively target antisense oligonucleotides to the source of disease

  January 9, 2020

   · 

  3 min read